Galmed Pharmaceutica (GLMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 09-2015 | 06-2015 | 03-2015 | 12-2014 | |
| Operating Expenses | 3,345 | 2,497 | 2,529 | 2,504 | 2,054 |
| Operating Income | -3,345 | -2,497 | -2,529 | -2,504 | -2,054 |
| Other Income | 140 | -103 | 175 | 41 | 76 |
| Pre-tax Income | -3,205 | -2,600 | -2,354 | -2,463 | -1,978 |
| Net Income Continuous | -3,205 | -2,600 | -2,354 | -2,463 | -1,979 |
| Net Income | $-3,205 | $-2,600 | $-2,354 | $-2,463 | $-1,979 |
| EPS Basic Total Ops | -53.99 | -41.40 | -37.80 | -39.60 | -32.40 |
| EPS Basic Continuous Ops | -51.97 | -42.16 | -38.17 | -39.94 | -29.49 |
| EPS Diluted Total Ops | -53.99 | -41.40 | -37.80 | -39.60 | -32.40 |
| EPS Diluted Continuous Ops | -51.97 | -42.16 | -38.17 | -39.94 | -29.49 |
| EBITDA(a) | $-3,430 | $-2,256 | $-2,361 | $-2,686 | $-2,053 |